Concepedia

Teresa Murray Law

TM

Statistics

Publications

6

Citations

552

H-Index

6

Active since

1994

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Teresa Murray Law is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, renal cell carcinoma, and pharmacology.

Publications per year

1994–2015

6

Publications

6

Phase iii randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma

Teresa Murray Law, Robert J. Motzer, Madhu Mazumdar et al. · Cancer · 1995 · 276 citations · Full text

, , +13

Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.

Robert J. Motzer, Lawrence B. Schwartz, Teresa Murray Law et al. · Journal of Clinical Oncology · 1995 · 153 citations

, , +17

Phase II trial of topotecan in patients with advanced renal cell carcinoma

Teresa Murray Law, David H. Ilson, Robert J. Motzer · Investigational New Drugs · 1994 · 44 citations

, , +10

A Phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma

William J. Berg, Lawrence H. Schwartz, Alison Amsterdam et al. · Investigational New Drugs · 1997 · 33 citations

, , +11

Phase II trial of liposomal encapsulated doxorubicin in patients with advanced renal cell carcinoma

Teresa Murray Law, Peter Mencel, Robert J. Motzer · Investigational New Drugs · 1994 · 27 citations

, , +14

1–5 of 6